Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patients with COVID-19 may face risk for liver injury

Key clinical point: Patients with COVID-19 may be at risk for liver injury, but mechanisms of damage remain unclear.

Major finding: The incidence of liver injury among patients with COVID-19 ranges from 15% to 53%.

Study details: A review detailing characteristics and mechanisms of liver injury caused by pathogenic coronavirus infections.

Disclosures: Fundamental Research Funds for the Central Universities supported the work. The investigators reported no conflicts of interest.


Xu L et al. Liver Int. 2020 Mar 14. doi: 10.1111/liv.14435.